{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 1, \"reasoning\": \"The candidate answer explicitly addresses coordination strategies for managing multiple proceedings under Section 2. This section covers lead forum selection, sequencing and stays (discussing Spiliada in the UK and forum non conveniens/comity in CA), anti-suit/anti-enforcement considerations (implicitly via enforcement risk mapping in Section 1C and sequencing in 2B), consolidation/coordination agreements (via the 'single global narrative' and 'disputes PMO'), protective orders and cross-use of evidence (Section 2C), and GDPR-compliant data-transfer safeguards (Section 2C). The response is comprehensive regarding this specific criterion.\", \"criterion_id\": \"166a0cb7-ac9b-463a-8b87-5f308e6b1465\"}", "usage": {"prompt_tokens": 4131, "completion_tokens": 182, "total_tokens": 4313}, "latency_s": 0.9213142080116086, "request_id": "hxeVaffwKrvzxs0P38eemAo", "raw_response": null}